As such, tau protein aggregation, neurofibrillary lesions, and cytoskeletal abnormalities are considered to be a central pathogenetic mechanism of AD (Šimić et al., 1998) important for its progressive nature (Clavaguera et al., 2009; Šimić et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.